Status:
COMPLETED
Galectin-3 Level in Ankylosing Spondylitis Patients
Lead Sponsor:
Recep Tayyip Erdogan University Training and Research Hospital
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18-70 years
Brief Summary
Forty-five AS patients and 35 healthy controls were enrolled in this study. Patients diagnosed with AS according to Modified New York criteria were included in the study. Clinical and laboratory measu...
Detailed Description
Detailed histories of all participants were obtained, and systemic and rheumatologic examinations were performed. We excluded all participants who had a history of hyperlipidemia, liver, renal, hemato...
Eligibility Criteria
Inclusion
- Ankylosing spondylitis patients
- Healthy controls
Exclusion
- Hyperlipidemia
- Liver diseases
- Renal diseases
- Hematological diseases
- Familial thyroid diseases
- Neoplastic diseases
- Autoimmune infectious diseases
- Receiving anti-inflammatory drugs.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04746196
Start Date
January 1 2017
End Date
August 30 2017
Last Update
April 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.